Jose Zayas
Plus aucun poste en cours
Historique de carrière de Jose Zayas
Anciens postes connus de Jose Zayas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ionetix Corp.
 Ionetix Corp. Medical SpecialtiesHealth Technology Ionetix Corp. engages in the development, manufacturing, and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. It offers ION-12SC, a positron emission tomography (PET) radiopharmaceutical production system for producing N-13 ammonia (13NH3), which is used in PET myocardial perfusion imaging. The company is headquartered in Marblehead, MA. | Conseiller Juridique Général | 01/01/2017 | 01/12/2018 |
| Zaycor Industries Corp. | Fondateur | - | - |
| TREX WIND-DOWN, INC. | Directeur des opérations | - | 16/07/2019 |
| Corporate Officer/Principal | - | - |
Formation de Jose Zayas
| The Ohio State University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| General Counsel | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
BioPharmX Corp.
 BioPharmX Corp. BiotechnologyHealth Technology BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA. | Health Technology |
Ionetix Corp.
Ionetix Corp. Medical SpecialtiesHealth Technology Ionetix Corp. engages in the development, manufacturing, and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. It offers ION-12SC, a positron emission tomography (PET) radiopharmaceutical production system for producing N-13 ammonia (13NH3), which is used in PET myocardial perfusion imaging. The company is headquartered in Marblehead, MA. | Health Technology |
| Zaycor Industries Corp. |
- Bourse
- Insiders
- Jose Zayas
- Expérience
